Access to Medical Marijuana
The Multiple Sclerosis Society of Canada welcomes the availability of safe and effective medications that provide people with MS and their physicians' choices in treating pain, which is a common symptom of the disease. Having available a variety of ways to manage pain is encouraging news.
In June 2013, the federal government announced new regulations to change the way Canadians access marihuana for medical purposes. In order to facilitate the transition from the current program to the new regulations, the new Marihuana for Medical Purposes Regulations (MMPR) operated concurrently with the Marihuana Medical Access Regulations (MMAR) until March 31, 2014.
Under the new regulations, individuals are no longer required to provide personal medical information to Health Canada or apply to the department for Authorization to Possess (ATP). Healthcare practitioners sign a medical document enabling individuals to purchase the appropriate amount for their medical condition from a Health Canada licensed producer.
Regulated, commercial licensed producers can produce a variety of marihuana strains and distribute it for medical purposes to registered individuals using a secure courier.
For more information:
Visit the website here